122333-98-6 Usage
Uses
Used in Pharmaceutical Industry:
2-(3-Methoxy-4-Methylphenyl)acetaldehyde is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique chemical structure allows for the development of new drugs with potential therapeutic benefits.
Used in Fragrance Industry:
In the fragrance industry, 2-(3-Methoxy-4-Methylphenyl)acetaldehyde is utilized as a component in creating complex and appealing scents. Its strong, sweet floral odor contributes to the overall aroma profile of perfumes and other fragranced products.
Used in Dye and Perfume Production:
2-(3-Methoxy-4-Methylphenyl)acetaldehyde serves as an important intermediate in the production of dyes and perfumes. Its chemical properties enable the creation of vibrant colors and captivating fragrances.
Used in Organic Compound Synthesis:
2-(3-Methoxy-4-Methylphenyl)acetaldehyde is also used as a building block in the synthesis of other organic compounds. Its reactivity and functional groups make it a valuable component in the development of new chemical entities with diverse applications.
Used in Medicinal Research:
2-(3-Methoxy-4-Methylphenyl)acetaldehyde has been studied for its potential medicinal properties, such as anti-inflammatory and antioxidant effects. Researchers are exploring its use in the development of new treatments for various health conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 122333-98-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,2,3,3 and 3 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 122333-98:
(8*1)+(7*2)+(6*2)+(5*3)+(4*3)+(3*3)+(2*9)+(1*8)=96
96 % 10 = 6
So 122333-98-6 is a valid CAS Registry Number.
122333-98-6Relevant articles and documents
Introduction of a putative dopaminergic prodrug moiety into a 6,7-substitution pattern characteristic of certain 2-aminotetralin dopaminergic agonists
Cannon,True,Long,Bhatnagar,Leonard,Flynn
, p. 2210 - 2214 (2007/10/02)
On the basis of the premise that the dopaminergic agonist profile of 2-(di-n-propylamino)-5-hydroxy-6-methyltetralin (1a) is due to in vivo oxidation of the 6-methyl moiety and that 1a may represent a novel prodrug strategy, the vicinal methyl-hydroxyl substitution pattern was incorporated into the 6- and 7-positions of 2-(di-n-propylamino)tetralin to give the 6-methyl-7-hydroxy and 6-hydroxy-7-methyl isomers 8 and 9, respectively. A multistep synthetic approach was devised which permitted preparation of target molecules 8 and 9. Pharmacological data revealed that both target compounds exhibit modest dopamine-like effects in the cardioaccelerator nerve assay in the cat, but neither appeared to be metabolically activated as was the case with 1a. The effects of 9 (but not of 8) were antagonized by pretreatment with haloperidol. Thus, the 5-hydroxy-6-methyl substition pattern in the 2-aminotetralins remains unique as a dopaminergic agonist prodrug structure.
